Regulus Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Regulus Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2012 to Q3 2024.
  • Regulus Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 65.5M shares, a 234% increase year-over-year.
  • Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 19M shares, a 24.2% increase from 2022.
  • Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 15.3M shares, a 78.1% increase from 2021.
  • Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 8.57M shares, a 75.5% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 65.5M +45.8M +234% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 64.5M +45.4M +237% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 28.7M +11.9M +70.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 19M +3.7M +24.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 19.6M +4.66M +31.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 19.1M +4.49M +30.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 16.8M +2.25M +15.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 15.3M +6.69M +78.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 15M +6.27M +72% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 14.6M +6.9M +89.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 14.6M -56.7M -79.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 8.57M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 8.7M -29.4M -77.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 7.72M -22.1M -74.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 71.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 38.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 29.8M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q3 2015 52M +8.58M +19.8% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-06
Q2 2015 51.1M +7.71M +17.8% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-05
Q3 2014 43.4M +3.25M +8.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 43.4M +7.37M +20.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q3 2013 40.2M -316M -88.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 36M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q3 2012 356M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.